Taher Uddin, Jing Xia, Yong Fu, et al. (incl. C. W. McNamara, A. K. Chatterjee, L. D. Sibley)
ACS Infectious Diseases, 2025; 11(3), 600-609.
Chronic Toxoplasma gondii infection persists as semidormant bradyzoites inside tissue cysts that current therapies cannot clear. The authors built a high-throughput phenotypic screen with a stage-specific luciferase reporter strain to measure bradyzoite growth inhibition, then screened a library of pharmacologically active compounds. They identified 44 compounds with more than 50% activity against bradyzoites, including sanguinarine sulfate, which rapidly killed bradyzoites in vitro and within intact cysts in chronically infected mice.
How Fluotics products were used: Parasite and compound suspensions were dispensed into the assay plates using a Fluotics BXi-50F (Beckman Biomek compatible 50 µL automation tips) while stirring the suspension at 350 rpm.
